1 completed, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow Functional Bowel Disorder: new trials by email Literature Review of Functional Bowel Disorder trials Research Report on Functional Bowel Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders Rifaximin (drug), Placebo - Bloating, Rifaximin | Phase 3 | Not yet recruiting | Mahidol University | 78 | 2026-12-01 | 2026-10-27 |
| Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders Mebeverine+Simethicone, Mebeverine, Simethicone - Functional Bowel Disorder | Phase 3 | Completed | Abbott | 465 | 2020-11-27 | 2025-09-16 |
Abdominal Pain (1) · Constipation (1) · Flatulence (1) · Irritable Bowel Syndrome (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Neurologic Manifestations (1) · Pain (1)
Pharmaceutical Preparations (1) · Rifaximin (1) · Simethicone (1) · mebeverine (1)
Abbott (1) · Mahidol University (1)
Russia (1) · Thailand (1)
Monthira Maneerattanaporn, M.D. (1) · Pubet Weeranawin, M.D. (1) · Somchai Leelakusolvong, M.D. (1) · Tanawat Geeratragool, M.D. (1)